Mondelez International, Inc. (MDLZ) › Analysis

Mondelez International, Inc. (MDLZ) analysis, February 17, 2026

Published February 17, 2026 · MDLZ chart, levels and live analysis

Key Updates

Mondelez shares declined 3.56% today to $60.36, erasing the recovery gains documented in the February 13 report and pushing the stock below the critical $61 support level. The 3.35% decline since the last report signals renewed selling pressure, with no new fundamental catalysts emerging to justify the pullback. The YTD performance remains solid at +12.13%, but the recent volatility underscores persistent investor concerns about muted 2026 growth guidance and elevated cocoa costs that will pressure margins throughout the year.

Current Trend

The stock has entered a corrective phase after testing resistance near $62.45 on February 13. The current price of $60.36 represents a breakdown below the $61 support level that had held during the post-earnings recovery. YTD performance of +12.13% remains constructive, outpacing the broader consumer staples sector, but the 2.77% decline over six months reflects ongoing fundamental headwinds. The 1-month gain of 5.45% is now being tested as profit-taking accelerates. Volume patterns suggest institutional repositioning ahead of March quarterly updates, with the $58-60 range representing critical near-term support established during the February 4 post-earnings selloff.

Investment Thesis

The core investment thesis centers on Mondelez's defensive characteristics combined with emerging market exposure (40% of sales) that provides superior growth potential versus domestic-focused peers. The company's portfolio of iconic brands (Oreo, Cadbury, Ritz) generates pricing power, while the 3.3% dividend yield offers income support during periods of volatility. Trading at 17x 2026 earnings with projected 10% earnings growth from 2026-2029, the valuation appears reasonable despite near-term margin compression from locked-in elevated cocoa costs. The 18% discount to Morningstar's fair value assessment suggests upside potential once cocoa headwinds abate in 2027. However, execution risks remain elevated given weak U.S. consumer demand, volume declines of 4.8 percentage points in Q4, and the company's conservative flat-to-2% organic revenue growth guidance for 2026.

Thesis Status

The investment thesis remains intact but faces near-term pressure. Today's 3.56% decline appears technical rather than fundamental, with no new negative catalysts emerging since the February 13 report. The key thesis elements—emerging market exposure, brand strength, and valuation discount—remain valid. However, the timing of the recovery has been pushed further into 2027, as cocoa cost relief will not materialize until 2027 according to management commentary. The 18% discount to fair value with 5-star Morningstar rating provides a margin of safety, but investors must endure continued margin pressure and weak U.S. consumer sentiment through 2026. The recent Marvel Oreo collaboration demonstrates continued innovation capability, but volume recovery remains the critical missing piece for thesis validation.

Key Drivers

The primary driver remains the cocoa cost headwind, with management indicating 2027 as the first year to benefit from lower cocoa prices despite spot prices declining 30% from May peaks. The company's hedging strategy locked in 2026 supplies at elevated rates, creating a structural margin headwind that pricing actions cannot fully offset. Consumer demand weakness represents the second critical factor, with management noting consumer confidence near historic lows and shoppers prioritizing essential foods over discretionary snacks. The U.S. biscuit business remains particularly weak, with households earning under $100,000 cutting back on discretionary spending. Competitive dynamics are intensifying, as Ferrero's $3.1 billion Kellogg acquisition positions the third-largest sweet packaged foods maker for aggressive U.S. expansion. Innovation initiatives like the Marvel Oreo collaboration with color-changing creme technology demonstrate brand vitality but require time to impact volumes materially.

Technical Analysis

MDLZ broke below the $61 support level established during the February 4-10 consolidation, with today's 3.56% decline on elevated volume suggesting capitulation by short-term holders. The stock now tests the $60 psychological support level, with the $58-60 range representing the next critical support zone from the post-earnings low. Resistance has formed at $62.45 (February 13 high), with the 50-day moving average likely converging near $61.50. The 12.13% YTD gain remains well above the 6-month performance of -2.77%, indicating a bifurcated trend where 2026 optimism clashes with fundamental reality. Volume patterns suggest institutional distribution rather than retail panic, with the stock likely to consolidate in the $58-62 range until Q1 2026 earnings provide clarity on volume trends. A breakdown below $58 would target the $55-56 range, while a recovery above $62 would retest the $64-65 resistance zone established in late 2025.

Bull Case

Bear Case

Get a message when the MDLZ picture changes — the agent team watches the levels and the news for you.Create a free account

More MDLZ analyses